Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
USE OF TUMOR INFLITRATING LYMPHOCYTES FOR TREATING NSCLC PATIENTS REFRACTORY FOR ANTI-PD-1 ANTIBODY
No-Receipt date
2024-01749 - 14/05/2024
No-Filing date
20240401103 - 14/05/2024
No-Granting date
3115382 - 24/05/2024
No-EPO application date
19856433.8 - 03/09/2019
No-EPO granting date
3843759 - 14/02/2024
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
5/2024 - 11/06/2024
Expiration date
04/09/2039
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201862725976 P31/08/2018/US
US201862726919 P04/09/2018/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 35/17
A61K 45/06
A61P 35/00
C12N 5/0781
C12N 5/0783
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1609116
IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD SUITE 400
SAN CARLOS, CA 94070
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
4192989
FARDIS, MARIA
4192990
NATARAJAN, ARVIND
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
9374
ANDRONIKI
MISIOU
MARATHONOS 27
VRILISIA (ATTIKIS)
15235
GREECE
Owners History
Title Instruments
Payments history
7 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).